Bevacizumab

NEW YORK — In this Healio Video Perspective from OSN New York Retina, Rishi P. Singh, MD, FASRS, of Cleveland Clinic Florida discusses the need for anti-VEGF biosimilars and the possibility of on-label bevacizumab.

PARK CITY, Utah — In this Healio Video Perspective from Clinical Trials at the Summit, Russ Trenary, president and CEO of Outlook Therapeutics, discusses the development of ONS-5010.

Durvalumab combined with transarterial chemoembolization and bevacizumab lengthened PFS among certain patients with hepatocellular carcinoma, according to the agent’s manufacturer.

The addition of atezolizumab to bevacizumab and first-line chemotherapy improved PFS and OS compared with standard chemotherapy alone among women with metastatic, persistent or recurrent cervical cancer, study results showed.

When it comes to naming children — at least in my generation — it was pretty straightforward.

SEATTLE — In eyes with center-involved diabetic macular edema, using bevacizumab first and switching to aflibercept if needed is more cost-effective over 2 years as compared with aflibercept monotherapy, according to DRCR Protocol AC.

The FDA approved trifluridine and tipiracil with bevacizumab for patients with previously treated metastatic colorectal cancer.

SEATTLE —There was no significant difference in cognitive outcomes for patients with retinopathy of prematurity treated with intravitreal bevacizumab compared with those treated with laser photocoagulation, according to a speaker here.

The addition of pembrolizumab to concurrent chemoradiotherapy conferred a statistically significant and clinically meaningful increase in PFS among women with newly diagnosed high-risk locally advanced cervical cancer, topline data showed.

CHICAGO — First-line chemotherapy plus bevacizumab and durvalumab — followed by maintenance durvalumab, bevacizumab and olaparib — extended PFS compared with standard of care for women with non-BRCA-mutated advanced ovarian cancer.